All Stories

  1. Principal component analysis, a useful tool to study CDK-inhibitor’s effect on cerebral ischemia
  2. Patent Foramen Ovale and Ischemic Stroke in Patients With Pulmonary Embolism
  3. Stroke Incidence and Case Fatality According to Rural or Urban Residence
  4. Blood transcriptomic biomarker as a surrogate of ischemic brain gene expression
  5. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial
  6. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
  7. Patent Foramen Ovale and Ischemic Stroke in Patients With Pulmonary Embolism
  8. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
  9. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
  10. Mouvements anormaux et dépôts métalliques intra-parenchymateux : à propos d’un cas
  11. Une fistule artérioveineuse vertébrale et une ischémie médullaire secondaires à une plaie par arme blanche
  12. Controlled Education of patients after Stroke (CEOPS)- nurse-led multimodal and long-term interventional program involving a patient’s caregiver to optimize secondary prevention of stroke: study protocol for a randomized controlled trial
  13. A Collet–Sicard syndrome due to internal carotid artery dissection associated with cerebral amyloid angiopathy–related inflammation
  14. Foreword
  15. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
  16. Functional impairments for outcomes in a randomized trial of unruptured brain AVMs
  17. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outc...
  18. Sustained (S)-roscovitine delivery promotes neuroprotection associated with functional recovery and decrease in brain edema in a randomized blind focal cerebral ischemia study
  19. The Changing Landscape for Stroke Prevention in AF
  20. AMOBES (Active Mobility Very Early After Stroke)
  21. Stroke at the beginning of the XXIst century
  22. Cryptogenic mechanism in ischaemic stroke patients is a predictor of 5-year survival: A population-based study
  23. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
  24. Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage
  25. Prognostic Significance of Hyponatremia in Acute Intracerebral Hemorrhage
  26. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial
  27. Quelle imagerie à la phase aiguë de l’accident vasculaire cérébral ischémique antérieur à l’heure du traitement endovasculaire ?
  28. Low Ambient Temperature and Intracerebral Hemorrhage: The INTERACT2 Study
  29. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome
  30. Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage
  31. Teaching NeuroImages: Ornithine transcarbamylase deficiency revealed by a coma in a pregnant woman
  32. Stroke with atrial fibrillation or atrial flutter: a descriptive population-based study from the Brest stroke registry
  33. Syndrome de la queue de cheval après une méningite à Neisseria meningitidis de type C
  34. Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2
  35. Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial
  36. Value of spontaneous hyperdensity of cerebral venous thrombosis on helical CT
  37. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
  38. High Completeness of the Brest Stroke Registry Evidenced by Analysis of Sources and Capture-Recapture Method
  39. Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage
  40. Vorapaxar in the Secondary Prevention of Atherothrombotic Events
  41. Cyclin-Dependent Kinase Inhibition With Roscovitine: Neuroprotection in Acute Ischemic Stroke
  42. Takotsubo syndrome associated with seizures: The visible part of the iceberg?
  43. Opalski syndrome detected on DWI MRI: A rare lateral medullary infarction. Case report and review
  44. Takotsubo syndrome associated with seizures: An underestimated cause of sudden death in epilepsy?
  45. Delayed Treatment with Systemic (S)-Roscovitine Provides Neuroprotection and Inhibits In Vivo CDK5 Activity Increase in Animal Stroke Models
  46. Microbleeds cérébraux
  47. Infarctus cérébraux cryptogéniques : de la classification au concept
  48. Cerebral ischemia, cell cycle elements and Cdk5
  49. Asomatognosie et troubles de l'oralité. Une lecture psychanalytique
  50. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia
  51. Spatiotemporal expression of noncatalytic TrkC NC2 isoform during early and late CNS neurogenesis: a comparative study with TrkC catalytic and p75NTRreceptors
  52. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death?
  53. Differential expression of TrkC catalytic and noncatalytic isoforms suggests that they act independently or in association
  54. Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein
  55. Evolving isolated hand palsy: a parietal lobe syndrome associated with carotid artery disease
  56. In situ expression of PLP/DM-20, MBP, and CNP during embryonic and postnatal development of the jimpy mutant and of transgenic mice overexpressing PLP
  57. Les accidents vasculaires cérébraux dans les services d'accueil et d'urgence
  58. Decrease in Internal Jugular Endothelin Levels After Carotid Cross-Clamping During Human Carotid Revascularization Procedures
  59. Embolism across the circle of Willis.
  60. Anomia for proper names after left thalamic infarct.
  61. Proteolipid protein interactions in transfectants: Implications for myelin assembly
  62. The role of the right medial temporal lobe in the control of memory-guided saccades
  63. The Proximal Region of theMBPGene Promoter is Sufficient to Induce Oligodendroglial-specific Expression in Transgenic Mice
  64. Brain infarction severity differs according to cardiac or arterial embolic source
  65. The DM20 Protein of Myelin: Intracellular and Surface Expression Patterns in Transfectants
  66. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism.
  67. DM-20 mRNA Is Expressed During the Embryonic Development of the Nervous System of the Mouse
  68. The anterior choroidal artery does not supply the corona radiata and lateral ventricular wall.